<?xml version="1.0" ?>


<rss version="2.0">
  <channel>
    <title>CRWENEWSWIRE1</title>
    <subtitle>Welcome to CRWENEWSWIRE1's Blog!</subtitle>
    <link>http://blogs.transworldnews.com/</link>
    <guid>http://blogs.transworldnews.com/</guid>
    <author>
        <name>TransWorldNews</name>
    </author>
    <copyright>Copyright (c) 2010 TransWorldNews.com</copyright>
    <language>en-us</language>

  <item>
    <title>U.S. Global Agreement to Make Strategic Investment in Galileo (GROW)</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176948</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176948</guid>
    <pubDate>Wed, 23 Jan 2013 16:10:08 GMT</pubDate>
    
    <category>Finance</category>
    <description>U.S. Global Investors, Inc. (NASDAQ: GROW) GROW (U.S. Global Investors) previously has entered into an agreement whereby U.S. Global will purchase 50 percent of the issued and outstanding shares of Toronto-based Galileo Global Equity Advisors Inc. (Galileo). Currently, all of the outstanding shares of Galileo are owned by Michael Waring. Upon completion of the transaction, Mr. Waring and GROW (U.S. Global Investors) will each own 50% of the outstanding shares of Galileo. Mr. Waring will continue to serve as the President, Chief Executive Officer and Chief Investment Officer of Galileo and will continue to have overall responsibility for the investment management activities of Galileo, including its management of the Galileo Mutual Funds. The transaction is subject to the approval of securities regulatory authorities and to the satisfaction of other closing conditions. It is anticipated that the transaction will close on or before March 31, 2013. U.S. Global Investors, Inc. (www.usfunds.com) (NASDAQ: GROW)</description>
  </item>

  <item>
    <title>Hanover Portfolio Acquisitions Signs Letter of Intent to Acquire Pain Management Medical Device Company Addressing Estimated $2.5 Billion U.S. Market</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176657</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176657</guid>
    <pubDate>Wed, 09 Jan 2013 15:21:29 GMT</pubDate>
    
    <category>Finance</category>
    <description>Pulsed Energy Replenisher (PER 2000) Is a Favorite of Shaquille O'Neal LOS ANGELES, CA--(CRWENewswire - Jan 8, 2013) - Hanover Portfolio Acquisitions ( OTCQB : HVPA ), an intellectual property licensing and commercialization company, has executed a Letter of Intent (LOI) to acquire 70% of Pulsed Energy Technologies, LLC and all of its intellectual property, assets, and accounts receivables. Upon completion of the acquisition, Hanover's wholly owned subsidiary, IP Resources International, will seek to establish distribution and licensing agreements in multiple international markets for the Pulsed Energy Replenisher (PER 2000) to augment current U.S. sales. This transaction would further expand Hanover's IP portfolio, which addresses the market for worldwide royalty and licensing fees estimated at $237 billion in 2011 according to the International Monetary Fund (IMF). Pulsed Energy Technologies is the developer, ISO-certified manufacturer, marketer, and distributor of the Pulsed Energy Replenisher (PER 2000),</description>
  </item>

  <item>
    <title>EQ Labs, Inc. and Crown Equity Holdings Inc. Announce Partnership Agreement</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176492</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176492</guid>
    <pubDate>Thu, 03 Jan 2013 07:28:30 GMT</pubDate>
    
    <category>Finance</category>
    <description>Las Vegas, NV  1/3/13 (CRWENewswire) EQ Labs, Inc. (EQLB) is pleased to announce its partnership with Crown Equity Holdings Inc. (CRWE) and its new board of directors members. Kenneth Bosket, Lowell Holden, Montse Zaman, Maurice Owens, Takeesha Owens, Dr. Westbrook Kaplan M.D. and State Representative Darryl Rouson of Florida. We are delighted to welcome the new members to the board I am confident that they will be a valuable asset to EQ Labs, Inc. moving forward in the energy drink industry, as well as in other endeavors stated Maurice Owens, CEO of EQ Labs, Inc. Mr. Owens also expressed his deep gratitude to the outgoing board members for their service and leadership during the past years. Both companies shall focus on restructuring EQ Labs, Inc. to add value to the company and its shareholders. About EQ Labs, Inc. EQ Labs, Inc. manufactures and markets energy drink products in the United States and Latin America. The company offers EQ Smart Energy Drink, in an effervescent tablet form that provides an</description>
  </item>

  <item>
    <title>LiveWire Ergogenics Secures Broker Representation for LiveWire Energy(TM) Products in Arizona, New Mexico and Southern California</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176449</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176449</guid>
    <pubDate>Tue, 01 Jan 2013 16:44:55 GMT</pubDate>
    
    <category>Finance</category>
    <description>ANAHEIM, CA--(CRWENewswire - Dec 28, 2012) - LiveWire Ergogenics, Inc. (OTCBB:LVVV) (OTCQB:LVVV) has secured broker representation for LiveWire Energy chews with Co-Sales Company, the leading independent grocery broker in the Southwestern United States. Co-Sales will provide LiveWire with product representation in the Arizona, New Mexico and Southern California markets. Co-Sales Company is headquartered in Phoenix, AZ and serves 11 states from 8 office locations in the western USA. Co-Sales will introduce LiveWire Energy chews to its broad network of grocery distributers, grocery store chains, convenience store chains and independent grocers in Arizona, New Mexico and Southern California. LiveWire CEO Bill Hodson commented, &quot;We're excited to enter the New Year with Co-Sales and the enthusiasm and capabilities that they bring to the table. Co-Sales is known as an innovator in the introduction of new products to its large client base. Co-Sales can also provide LiveWire with access to national markets through</description>
  </item>

  <item>
    <title>World Moto, Inc.: Selects SVI as Its Manufacturing Partner for the Moto-Meter</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176327</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176327</guid>
    <pubDate>Wed, 26 Dec 2012 13:16:15 GMT</pubDate>
    
    <category>Finance</category>
    <description>BANGKOK, THAILAND--(CRWENewswire - Dec 24, 2012) - World Moto, Inc. (OTCBB:FARE) (OTCQB:FARE) (BERLIN:WM7) (BERLIN:A1J8SY) (&quot;World Moto&quot; or the &quot;Company&quot;) is pleased to announce that it has selected Thailand-based SVI Public Company Ltd (&quot;SVI&quot;) as its manufacturing partner for production of the Moto-Meter (www.svi.co.th). This strategic decision allows World Moto to scale its production rapidly to meet demand for the device. Changing the way the world goes around, World Moto is a global authority on the $500 billion dollar a year motorcycle taxi industry and inventor of the Moto-Meter, the world's first motorcycle taxi meter. World Moto's CTO Chris Ziomkowski revealed, &quot;The Moto-Meter is one of the most innovative technologies ever to be developed for the motorcycle taxi industry. It is absolutely critical that we partner with a firm that has the capability to provide the kind of state of the art testing that is required to guarantee the proper functioning of this revolutionary device.&quot; The decision allows</description>
  </item>

  <item>
    <title>World Moto Completes Successful Moto-Meter Trials in Bangkok -- Worldwide Motorcycle Meter Is a $3 Billion Industry</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176147</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176147</guid>
    <pubDate>Wed, 19 Dec 2012 10:13:20 GMT</pubDate>
    
    <category>Finance</category>
    <description>BANGKOK, THAILAND--(CRWENewswire - Dec 18, 2012) - World Moto, Inc. (OTCBB:FARE) (OTCQB:FARE) (FRANKFURT:WM7) (FRANKFURT:A1J8SY) (&quot;World Moto&quot; or the &quot;Company&quot;) is pleased to announce that the Company has successfully completed comprehensive street trials of the Company's revolutionary Moto-Meter in Bangkok, Thailand. Changing the way the world goes around, World Moto is a global authority on the $500 billion dollar a year motorcycle taxi industry and inventor of the Moto-Meter, the world's first motorcycle taxi meter. World Moto partnered with the Bangkok Governor's Office to carry out the trials which were conducted to test both the hardware and software of the meter as well as to determine how quickly it could be deployed throughout the city. The trials were carried out along a prominent thoroughfare in the heart of the city and received universal praise from both drivers and passengers. Bangkok's Deputy Governor, Mrs. Taya Teepsuwan, acknowledged that &quot;The Moto-Meter is an exciting project that will be an</description>
  </item>

  <item>
    <title>AVT Updates Financial Forecast</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176086</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176086</guid>
    <pubDate>Mon, 17 Dec 2012 14:15:01 GMT</pubDate>
    
    <category>Finance</category>
    <description>Revised revenues forecasted at over $50 million by 2014 CORONA, Calif., Dec. 17, 2012 (CRWENewswire) -- AVT, Inc. (OTC Bulletin Board:AVTC) (www.autoretail.com) updated its financial guidance for the periods through 2014. The move came after the recent new orders from large customers exceeded expectations. The company's planned expansion into new markets, products and services is moving ahead of schedule. As a leader in providing customized automated solutions to retailers, businesses, brand owners and entrepreneurs, AVT is poised to significantly increase revenues in the next 24 months. RECURRENT REVENUE AVT is targeting a new market niche, by both building and operating a significant number of the new automated Marley Coffee Stores. These innovative systems provide customers with the world's finest blends and a coffee-shop experience, but without the wait and at about half the cost. The company plans on deploying 1000 of these units by the end of 2013. NEW DIVISIONS AVT has also recently created a new</description>
  </item>

  <item>
    <title>Casablanca Mining Announces Constitution of Claims on Free Gold Property</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176051</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=176051</guid>
    <pubDate>Sun, 16 Dec 2012 16:09:01 GMT</pubDate>
    
    <category>Finance</category>
    <description>SAN DIEGO, Dec 14, 2012 (CRWENewswire) -- CASABLANCA MINING (otcqx:CUAU) announced today that its wholly-owned subsidiary, Santa Teresa Minerals, S.A., has completed the &quot;Sentencia Constitutiva&quot; (constitution) of mining claims Tauro 1, 2, 3 (655 acres). The Company is now authorized to solicit the exploitation of these 3 properties at Free Gold. They will continue the claim perfection process at Estero 1, 2, 3, 4, 5 (1,235 acres) and are pursuing exploitation permits from Conaf (Corporacion Nacional Forestal), Sernageomin (Servicio Nacional de Mineria y Geologia) and DGA (Direccion General de Aguas). The Company will solicit property access rights in order to begin the exploitation phase after the constitution is published in Chile. The link below will provide photos from the property during the exploration phase in June 2012: http://www.buyins.com/freegoldphotos.pdf Additionally, a detailed review of the mineral exploration and development activities at the Company's Free Gold Property (&quot;the Property&quot;) in</description>
  </item>

  <item>
    <title>ASML and Cymer provide transaction status update</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175996</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175996</guid>
    <pubDate>Fri, 14 Dec 2012 09:03:24 GMT</pubDate>
    
    <category>Finance</category>
    <description>VELDHOVEN, The Netherlands and SAN DIEGO, Dec. 14, 2012 (CRWENewswire)-- ASML Holding NV (Nasdaq:ASML) and Cymer, Inc. (Nasdaq:CYMI) today provide a status update regarding ASML's previously announced pending acquisition of all of the outstanding shares of Cymer in a cash-and-stock transaction that will entitle each Cymer stockholder to receive US$20.00 in cash and a fixed ratio of 1.1502 ASML ordinary shares per Cymer share. Cymer has established Tuesday, 5 February 2013 as the date on which it will hold a special shareholders meeting at which the stockholders of record of Cymer as of 7 January 2013 will be asked to vote on, among other things, a proposal to approve the merger agreement, dated 16 October 2012, among ASML and Cymer and certain affiliates of ASML. The parties expect that a proxy statement/prospectus will be mailed to Cymer's stockholders in early January 2013. In addition, ASML and Cymer indicated that they are continuing to work with various regulators. This includes responding to a request</description>
  </item>

  <item>
    <title>China Yuchai Leads Natural Gas Bus Engine Market in Shaanxi Province</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175888</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175888</guid>
    <pubDate>Wed, 12 Dec 2012 07:55:38 GMT</pubDate>
    
    <category>Finance</category>
    <description>SINGAPORE, Dec. 12, 2012 (CRWENewswire) -- China Yuchai International Limited (NYSE:CYD) (&quot;China Yuchai&quot; or the &quot;Company&quot;), announced today that natural gas engines produced by the Company's main operating subsidiary, Guangxi Yuchai Machinery Company Limited (&quot;GYMCL&quot;), have been penetrating the key Shaanxi Province market in North-West China since their introduction in early 2012. GYMCL's natural gas engines have enjoyed significant demand by municipal bus, tour coach and school bus operators in various Shaanxi municipalities including Yulin, Baoji, Yan'an, Tongchuan and Hanzhong. After the delivery of the first batch of buses using GYMCL's natural gas engines to the Bus Industry (Xi'an) Co., Ltd. in Shaanxi Province in February 2012, a number of the province's passenger transport and bus companies started to purchase GYMCL's natural gas engines for the first time. GYMCL managed to break through in Shaanxi Province by employing an active marketing campaign to publicize the advantages of GYMCL's natural gas</description>
  </item>

  <item>
    <title>iMing Corp. Plans to Open a E-Commerce Online Retail Store</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175817</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175817</guid>
    <pubDate>Mon, 10 Dec 2012 17:04:46 GMT</pubDate>
    
    <category>Finance</category>
    <description>HONG KONG, CHINA--(CRWENewswire - Dec. 10, 2012) - iMing Corp. (OTC PINK:IMNG) announced today that the company plans to open a E-commerce online retail store at Taobao Marketplace. Taobao Marketplace is a Chinese language web site for online shopping, similar to eBay and Amazon, operated in China. Founded by Alibaba Group in May 10, 2003, Taobao Marketplace facilitates consumer-to-consumer (C2C) retail by providing a platform for small businesses and individual entrepreneurs to open online retail stores that mainly cater to consumers in mainland China, Hong Kong, Macau and Taiwan. Taobao Marketplace (formerly &quot;Taobao&quot;) was launched in May 2003 by Alibaba Group after eBay acquired Eachnet, China's online auction leader at the time, for US$180 million and became the major player in the Chinese consumer e-commerce market. To counter eBay's expansion, Taobao offered free listings to sellers and introduced website features designed to better cater to local consumers, such as an instant messaging tool for</description>
  </item>

  <item>
    <title>China BAK is selected into the National Support List for the New-Energy Vehicle Industry Innovation Program</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175686</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175686</guid>
    <pubDate>Mon, 10 Dec 2012 07:15:20 GMT</pubDate>
    
    <category>Finance</category>
    <description>SHENZHEN, China, Dec. 10, 2012 (CRWENewswire) -- China BAK Battery, Inc. (&quot;China BAK&quot;, the &quot;Company&quot;, or &quot;we&quot;) (Nasdaq:CBAK), a leading global manufacturer of lithium-based battery cells, today announced that the Company's Technical R&amp;D Program in Key Materials, Battery and Battery Pack for use in Electric Vehicles (&quot;EV&quot;) was selected into the National Support List for the New-Energy Vehicle Industry Innovation Program as issued by the Ministry of Finance, the Ministry of Information Technology and the Ministry of Science and Technology of the People's Republic of China on December 3, 2012 (&quot;Innovation Program&quot;). According to the notice ( http://www.gov.cn/zwgk/2012-12/03/content_2281019.htm) jointly issued by the above three ministries, to promote the development of new-energy vehicle industry in China, the Chinese government intends to provide financial supports to 25 selected new-energy vehicles related projects, among which 8 projects, including China BAK's, are battery research and development programs.</description>
  </item>

  <item>
    <title>Data From Non HSCT VOD Patients Treated With Defibrotide and a Treatment IND Update to be Presented at the American Society of Hematology Annual Meeting</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175579</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175579</guid>
    <pubDate>Fri, 07 Dec 2012 08:14:59 GMT</pubDate>
    
    <category>Finance</category>
    <description>VILLA GUARDIA (COMO), Italy, Dec. 7, 2012 (CRWENewswire) -- Gentium S.p.A. (Nasdaq:GENT) (the &quot;Company&quot;) today announced that an oral presentation and poster abstracts on Defibrotide will be presented at the 54th Annual Meeting and Exposition of the American Society of Hematology to be held at the Georgia World Congress Center in Atlanta, Georgia, December 8-11, 2012. Oral Presentation Results of a Large Prospective Study on the Use of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome -- Updated Results of a Treatment IND (T-IND) Expanded Access Protocol. Monday, December 10, 2012: 5:45 PM C101, Level 1, Building C. Paul G. Richardson, MD at Dana Farber Cancer Institute, Boston, MA. Poster Abstracts Evaluation of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in non-Stem Cell Transplant (non-SCT) Chemotherapy Patients: Results from the Treatment IND (T-IND) Expanded Access Protocol and</description>
  </item>

  <item>
    <title>Lockheed Martin's PAC-3 MSE Missile Successfully Intercepts Tactical Ballistic Missile Target During Test</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175533</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175533</guid>
    <pubDate>Thu, 06 Dec 2012 13:34:02 GMT</pubDate>
    
    <category>Finance</category>
    <description>DALLAS, Dec. 6, 2012 (CRWENewswire) -- Lockheed Martin's (NYSE:LMT) PAC-3 Missile Segment Enhancement (MSE) successfully engaged, intercepted and destroyed a tactical ballistic missile (TBM) target today at White Sands Missile Range, N.M. The first interceptor destroyed the target and the second PAC-3 MSE Missile self-destructed as planned. &quot;Today's flight test provided another example of how the PAC-3 MSE Missile has significantly expanded the Patriot battlespace, engaging a TBM at unprecedented range,&quot; said Richard McDaniel, vice president of PAC-3 programs at Lockheed Martin Missiles and Fire Control. &quot;This test was especially satisfying as it came just a few days after the first successful Medium Extended Air Defense System (MEADS) intercept flight test in which another PAC-3 MSE Missile intercepted a threat representative air-breathing target in an over-the-shoulder engagement.&quot; The PAC-3 MSE Missile provides increased performance by expanding the lethal battlespace of the current PAC-3 Missile both in</description>
  </item>

  <item>
    <title>Achmea (Australia) Selected Sapiens IDIT Software Suite</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175470</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175470</guid>
    <pubDate>Wed, 05 Dec 2012 08:18:54 GMT</pubDate>
    
    <category>Finance</category>
    <description>Following Achmea's selection of Sapiens IDIT as its strategic global solution across all operating companies in the group REHOVOT, Israel, December 5, 2012 (CRWENewswire) --Sapiens International Corporation N.V. (NASDAQ and TASE: SPNS), a provider of innovative insurance software solutions and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announces today that Achmea Insurance Group have selected Sapiens IDIT software suite as their centralized solution for core General Insurance business in Australia. This Greenfield operation is conducted by Achmea Australia, who will serve as the insurer's main distribution channel on the ground. This Sapiens IDIT deployment follows the successful implementations of Sapiens IDIT Software Suite in Interamerican (Bulgaria) and Oranta (Russia), members of the Achmea Group, and the decision of Achmea to select Sapiens IDIT as the strategic software solution across all operating companies within the group. Timo van Voorden, CEO of Achmea Australia, commented: &quot;I</description>
  </item>

  <item>
    <title>Galena Biopharma Announces Signature of Commercialization Partnership With Teva for Israel</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175411</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175411</guid>
    <pubDate>Tue, 04 Dec 2012 07:55:54 GMT</pubDate>
    
    <category>Finance</category>
    <description>Partnership includes future commercialization of NeuVax(TM) in Israel and financial support 

 Key clinical sites approved and established in Israel for PRESENT Phase 3 trial LAKE OSWEGO, Ore., Dec. 4, 2012 (CRWENewswire) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments, today announced it has signed an agreement with a subsidiary of Teva Pharmaceutical Industries Limited for the commercialization of NeuVax(TM) (nelipepimut-S or E75) in Israel. &quot;This agreement is the first piece of our global commercialization strategy,&quot; said Mark Ahn, Ph.D., President and Chief Executive Officer, Galena Biopharma. &quot;Teva is a world-class pharmaceutical company and a major pharmaceutical company in Israel. We look forward to their valuable financial support towards our development goals in Israel, as well as market leadership for NeuVax commercialization in the region.&quot; Under the agreement, Teva Israel will assume responsibility for regulatory</description>
  </item>

  <item>
    <title>PEEK Extends Tender Offer for Shares of LookSmart Until December 31, 2012</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175373</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175373</guid>
    <pubDate>Mon, 03 Dec 2012 07:44:31 GMT</pubDate>
    
    <category>Finance</category>
    <description>NEW YORK, Dec. 2, 2012 (CRWENewswire) -- PEEK Investments LLC today issued the following statement: &quot;We have extended our third-party tender offer to purchase all of the outstanding shares of common stock of LookSmart, Ltd. (Nasdaq:LOOK) for $1.00 per share in cash. As extended, the tender offer is scheduled to expire at 5:00 P.M., New York time, on December 31, 2012. The tender offer was previously scheduled to expire at 5:00 P.M., New York time, on November 30, 2012. As of November 30, 2012, 4,730,028 shares had been deposited, which, together with the shares owned by PEEK's affiliates, represents approximately 42% of the total shares outstanding. We extended the tender offer because we are currently engaged in negotiations with LookSmart with respect to possible board representation rights and related agreements and transactions. However, we cannot guarantee that the negotiations will be successful or that the tender offer will be consummated even if the negotiations are successful.&quot; About PEEK Investments</description>
  </item>

  <item>
    <title>Whole Foods Market Announces Special Cash Dividend of $2.00 Per Share</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175297</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175297</guid>
    <pubDate>Fri, 30 Nov 2012 08:44:00 GMT</pubDate>
    
    <category>Finance</category>
    <description>AUSTIN, Texas, Nov. 29, 2012 (CRWENewswire) -- Whole Foods Market, Inc. (Nasdaq:WFM) announced that its Board of Directors has declared a special cash dividend on Whole Foods Market common stock of $2.00 per share payable December 21, 2012, to shareholders of record on the close of business on December 10, 2012. The aggregate amount of payment to be made in connection with this special dividend will be approximately $370 million. &quot;Today's announcement of a $2.00 special dividend, payable prior to the end of the calendar year, provides us with another opportunity to return capital to our shareholders,&quot; said John Mackey, co-founder and co-chief executive officer of Whole Foods Market. &quot;We believe we will continue to generate strong cash flows and are confident in our ability to maintain a healthy cash reserve, internally fund our accelerated growth plans, and continue our quarterly dividend and stock repurchase programs.&quot; The special dividend is in addition to the Company's regular quarterly cash dividend of</description>
  </item>

  <item>
    <title>Grace Completes the Acquisition of Assets of Noblestar Catalysts</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175250</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175250</guid>
    <pubDate>Thu, 29 Nov 2012 09:37:21 GMT</pubDate>
    
    <category>Finance</category>
    <description>QINGDAO, China--(CRWENewswire)--W. R. Grace &amp; Co. (NYSE:GRA) announced today that it has completed its acquisition of the assets of Noblestar Catalysts Co., Ltd, a Qingdao, China-based manufacturer of fluid catalytic cracking (FCC) catalysts, catalyst intermediates and related products used in the petroleum refining industry. Grace is the worldwide leader in FCC catalysts. Qingdao Bureau of Commerce Vice Director General, Cong Yan, welcomed Graces investment during the ribbon cutting ceremony and said, Qingdao is a leading economic center in China. We welcome foreign investment, especially from companies like Grace, which has world-class, leading technologies that can help develop our fast-growing petrochemical industry while also acknowledging environmental and safety concerns. The successful acquisition of Noblestars assets in Qingdao is another milestone in Graces long relationship with China. And it is an important step in our strategy to provide world-class products and support to the petroleum</description>
  </item>

  <item>
    <title>Cadence Pharmaceuticals Announces Settlement of OFIRMEV&#174; (Acetaminophen) Injection Patent Litigation with Perrigo Company</title>
    <link>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175191</link>
    <guid>http://blogs.transworldnews.com/ken1/Post.aspx?postID=175191</guid>
    <pubDate>Wed, 28 Nov 2012 08:55:12 GMT</pubDate>
    
    <category>Finance</category>
    <description>SAN DIEGO, Nov. 28, 2012 (CRWENewswire) -- Cadence Pharmaceuticals, Inc. (Nasdaq:CADX) today announced that it has entered into settlement and license agreements with Perrigo Company (Nasdaq:PRGO; TASE), and its subsidiary, Paddock Laboratories, LLC, to resolve pending patent litigation involving OFIRMEV&#174; (acetaminophen) injection. The settlement agreement includes a stipulation by the parties requesting dismissal with prejudice of the lawsuit filed by Cadence in the U.S. District Court for the District of Delaware relating to the Abbreviated New Drug Application, or ANDA, filed by Paddock with the U.S. Food and Drug Administration for a generic version of OFIRMEV&#174; (acetaminophen) injection. Litigation remains ongoing against Exela Pharma Sciences, LLC, Exela PharmaSci, Inc. and Exela Holdings, Inc. Under the license agreement, Perrigo has been granted the exclusive right of first refusal to negotiate an agreement with Cadence to market an authorized generic version of OFIRMEV (i.e., a generic version</description>
  </item>

  </channel>
</rss>    




